Shots: The approval is based on P-III Lampit study assessing nifurtimox in 330 children with chagas disease with serologic evidence of T. cruzi infection in a ratio (2:1) to receive […]readmore
Tags : Nifurtimox
Shots: TheP-III CHICO study involves assessing of Nifurtimox (120mg/30mg) vs PBO in 330 pediatric patients with acute or chronic Chagas disease across 25 sites including Argentina, Bolivia, and Colombia The […]readmore